Cancer diagnostics
These companies sell tests that detect, profile or monitor cancer from tissue or blood to guide treatment.
−0.3%
over 1 year · S&P 500 +11.6%
Key indicators
Health
52 / 100
Fragile
Solid
Price
P/E 40
Cheap
Expensive
Up over 1 year
9 of 15
Volatility
70%
Calm
Choppy
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 15 companies
ABT
−14.2%
NTRA
+52.3%
GH
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
A
Abbott Laboratories
ABT
61.7%
−14.2%
N
Natera
NTRA
15.3%
+52.3%
G
Guardant Health
GH
6.7%
+55.0%
T
Tempus AI
TEM
4.7%
+0.7%
C
Caris Life Sciences
CAI
2.3%
−7.0%
G
GRAIL
GRAL
1.8%
+36.7%
B
BillionToOne
BLLN
1.8%
+3.3%
A
Adaptive Biotechnologies
ADPT
1.5%
+100.3%
C
CareDx
CDNA
1.4%
+377.5%
N
NeoGenomics
NEO
0.7%
+60.2%
V
Veracyte
VCYT
0.6%
−42.5%
P
Personalis
PSNL
0.6%
+96.1%
F
Freenome
FRNM
0.4%
−3.4%
C
Castle Biosciences
CSTL
0.3%
−3.0%
M
Myriad Genetics
MYGN
0.2%
−13.5%